Menu
GeneBe

10-26219128-A-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001134366.2(GAD2):c.372A>C(p.Lys124Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000614 in 1,613,522 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.

Frequency

Genomes: 𝑓 0.00037 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000029 ( 0 hom. )

Consequence

GAD2
NM_001134366.2 missense

Scores

5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.40
Variant links:
Genes affected
GAD2 (HGNC:4093): (glutamate decarboxylase 2) This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.038317144).
BS2
High AC in GnomAd at 57 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GAD2NM_001134366.2 linkuse as main transcriptc.372A>C p.Lys124Asn missense_variant 4/16 ENST00000376261.8
GAD2NM_000818.3 linkuse as main transcriptc.372A>C p.Lys124Asn missense_variant 4/17

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GAD2ENST00000376261.8 linkuse as main transcriptc.372A>C p.Lys124Asn missense_variant 4/161 NM_001134366.2 P1

Frequencies

GnomAD3 genomes
AF:
0.000375
AC:
57
AN:
152162
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000956
GnomAD3 exomes
AF:
0.0000877
AC:
22
AN:
250948
Hom.:
0
AF XY:
0.0000737
AC XY:
10
AN XY:
135642
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.0000582
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000287
AC:
42
AN:
1461242
Hom.:
0
Cov.:
31
AF XY:
0.0000234
AC XY:
17
AN XY:
726854
show subpopulations
Gnomad4 AFR exome
AF:
0.000956
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
AF:
0.000374
AC:
57
AN:
152280
Hom.:
1
Cov.:
33
AF XY:
0.000389
AC XY:
29
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.00120
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000946
Alfa
AF:
0.0000749
Hom.:
0
Bravo
AF:
0.000495
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000115
AC:
14

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 01, 2024The c.372A>C (p.K124N) alteration is located in exon 4 (coding exon 4) of the GAD2 gene. This alteration results from a A to C substitution at nucleotide position 372, causing the lysine (K) at amino acid position 124 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.42
Cadd
Benign
21
Dann
Uncertain
0.99
DEOGEN2
Uncertain
0.72
D;D;.
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.29
FATHMM_MKL
Uncertain
0.89
D
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.038
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Uncertain
2.1
M;M;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-2.3
N;N;.
REVEL
Benign
0.14
Sift
Benign
0.043
D;D;.
Sift4G
Benign
0.20
T;T;.
Polyphen
0.055
B;B;.
Vest4
0.37
MutPred
0.19
Gain of helix (P = 0.0034);Gain of helix (P = 0.0034);.;
MVP
0.46
MPC
0.52
ClinPred
0.068
T
GERP RS
-1.1
Varity_R
0.47
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs8190600; hg19: chr10-26508057; API